Meta-analysis on the effect of dopexamine on in-hospital mortality.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 19453310.
- Also identified by DOI 10.1111/j.1365-2044.2009.05896.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of the study was to determine whether dopexamine alters in-hospital mortality. The following databases were searched, Embase (1974-July 2007), Medline (1950-July 2007), CINAHL, PubMed and Cochrane Clinical Register of Controlled Trials (CENTRAL). Two reviewers independently checked the quality of the studies and extracted data. Six randomised controlled trials totalling 935 patients were included. Mortality was not significantly different with dopexamine treatment (relative risk 0.75, 95% confidence interval 0.48-1.18, p = 0.22). In conclusion, dopexamine does not improve in-hospital mortality in patients undergoing major abdominal surgery and in the critically ill.
Medical subject headings
- Adrenergic beta-Agonists
- Dopamine
- Perioperative Care
- Vasodilator Agents